NCT05389163

Brief Summary

Class V carious lesions will be restored using either Resin modified glass ionomer or Giomer based injectable resin composite.The restorations will be evaluated at baseline and regular recalls of 3 months, 6 months, 12 months and 18 months, using modified United States Public Health Service criteria.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

July 17, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2024

Completed
Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

1.7 years

First QC Date

May 12, 2022

Last Update Submit

July 9, 2024

Conditions

Keywords

Giomerinjectable resin compositeResin modified glass ionomer

Outcome Measures

Primary Outcomes (1)

  • Clinical performance (Marginal adaptation)

    Method of measurement is Modified United State Public Health Service Criteria (Modified USPHS) using (Alpha, Bravo, charlie) as unit of measurement by Scoring %. Alpha is the best outcome and charlie is the worse outcome .

    18 months

Secondary Outcomes (1)

  • Clinical performance (Anatomical form, marginal discoloration, Secondary caries, surface texture , Postoperative sensitivity, Retention,)

    18 months

Study Arms (2)

Giomer based injectable resin composite

EXPERIMENTAL

Beautifil Flow plus X F03, SHOFU, USA

Device: Giomer based injectable resin composite

Resin modified glass ionomer

ACTIVE COMPARATOR

Fuji II LC, GC

Device: Resin modified glass ionomer

Interventions

Giomer material has been introduced as the true hybridization of glass ionomer and resin composite, containing surface pre-reacted glass ionomer (S-PRG) filler particles within a resin matrix. Giomer combines caries protection through fluoride release and recharge of glass ionomers and the esthetics, physical and handling properties of resin composite

Giomer based injectable resin composite

Resin modified glass ionomer (RMGI) have been developed to combine the advantages of both resin composite and glass ionomer; the good mechanical properties, esthetic of resin composite added to anticariogenic activity and chemical bonding to tooth structure of glass Ionomer.

Resin modified glass ionomer

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-60 years.
  • Co-operative patients approving to participate in the study.
  • Male or female patients.
  • Patients with good general health
  • Moderate or high caries risk patient
  • Cervical Class V carious lesions.
  • Pulp asymptomatic vital carious teeth.

You may not qualify if:

  • Systemic disease or severe medical complications.
  • Participants with a history of allergy to any component of restorations will be used in the study.
  • Lack of compliance
  • Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits
  • Presence of apical or periapical pathosis.
  • tooth mobility
  • Non-vital teeth.
  • Teeth with advanced periodontal diseases.
  • Teeth which need indirect restoration.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer at conservative department,,faculty of dentistry, modern university for Technology and Information.

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 25, 2022

Study Start

July 17, 2022

Primary Completion

April 5, 2024

Study Completion

July 4, 2024

Last Updated

July 10, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Expecting to have all the data by October 2024

Locations